Last Updated
Mar 12, 2009

International Collaborations in Infectious Disease Research (ICIDR) (U01)

Description

This FOA invites applications from U.S. institutions proposing collaborative research with foreign [non-U.S.] investigators and organizations focused on infectious diseases that disproportionately affect the health of people living in resource-constrained countries.  The ICIDR program is intended to support research requiring access to populations of infected human and other mammalian hosts, parasites, and vectors limited or unavailable in the U.S. and other developed countries.  Therefore, the majority of research supported under the ICIDR program must be conducted at foreign sites with an emphasis on field and clinical studies of endemic diseases.  A non-U.S investigator at the foreign site will serve as a Major Foreign Collaborator (MFC).  The MFC must be listed as key personnel and have a primary appointment at a collaborating institution in an eligible foreign country. The MFC must have a significant role in the design, implementation, monitoring, and administrative management of the research projects.   

Eligible Entities

The following organizations/institutions are eligible to apply:

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education
  • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • For-Profit Organizations (Other than Small Businesses)
  • State Governments
  • County Governments
  • City or Township Governments
  • Special District Governments
  • Regional Organizations
  • Other(s): Eligible Agencies of the Federal Government
    • Faith-based or Community-based Organizations.

Available Funds

The NIAID expects to award $6.3 million in total costs in response to this FOA to support 5 to 9 new and/or competing renewal grants.

The total project period for an application submitted in response to this funding opportunity may not exceed five years. Direct costs are limited to $500,000 in year 1.  Future year recommended levels are limited to 3% escalation costs.

Cost Sharing

This program does not require cost sharing as defined in the current NIH Grants Policy Statement.

Facilities and Administrative Costs

Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation, see NOT-OD-05-004.

Key Dates

  • Release Date:  March 6, 2009
  • Letters of Intent Receipt Date: June 23, 2009
  • Application Receipt Date: July 23, 2009
  • Peer Review Date: November, 2009
  • Council Review Date: January, 2010
  • Earliest Anticipated Start Date: May, 2010
  • Additional Information To Be Available Date (Url Activation Date): http://www.niaid.nih.gov/ncn/budget/qa/  Expiration Date: July 24, 2009

More Info + Submissions

Agency: National Institutes of Health (NIH)
Expires: July 23, 2009

Submissions for this opportunity are not handled by RI STAC or RI EPSCoR. Please follow the link below for more information on the opportunity and how to submit a response.